Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03313557
Title AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | FRA

Facility Status City State Zip Country Details
Research Site Bingham Farms Michigan 48025 United States Details
Research Site Detroit Michigan 48202 United States Details
Research Site Lebanon New Hampshire 03756 United States Details
Research Site Cincinnati Ohio 45229 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Greenville South Carolina 29605 United States Details
Research Site Dallas Texas 75251 United States Details
Research Site Bordeaux Cedex 33075 France Details
Research Site Saint Herblain Cedex 44805 France Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Amsterdam 1081 HV Netherlands Details
Research Site Maastricht 6202 AZ Netherlands Details
Research Site Glasgow G12 0YN United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field